FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288753695> ?p ?o ?g. }

• W4288753695 endingPage "100163" @default.
• W4288753695 startingPage "100163" @default.
• W4288753695 abstract "Improvements in chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) treatment options have increased the 5-year survival rates for patients with these hematologic malignancies. In addition to cancer management, these patients may need help to manage multiple chronic conditions (MCC). The overall objective of this study is to examine the impact and implementation of a model that coordinates care between oncology and primary care pharmacists for people taking an oral anti-cancer agent (OAAs) and medications for comorbid chronic conditions. This is a multi-center, prospective, single-arm pilot study that will recruit up to 40 patients from Michigan Medicine and Vanderbilt University Medical Center (VUMC). Eligible participants will be 18 years of age or older, prescribed an OAA, have a diagnosis of either CML, CLL or MM, and be diagnosed with and taking medication for at least two specified chronic conditions. The Pharmacists Coordinated Care Oncology Model (PCOM) is a two-month intervention that builds upon current pharmacist clinical responsibilities. Generally, participants will complete a patient-reported outcome measure at 2 and 6 weeks post-OAA initiation that is sent to their oncology pharmacist, and they will also receive a comprehensive medication review at week 4 from a primary care pharmacist for their chronic medications. The pharmacists will communicate about the results via electronic medical record (EMR) and intervene if necessary. The primary endpoints are (1) dose-adjusted OAA proportion of days covered (PDC), and (2) PDC for chronic condition medications. PDCs will be determined via prescription records. The association of OAA and chronic medication PDCs will be quantified via correlation and chi-squared tests. The association between symptom experience and OAA adherence will be examined via correlation analyses. For implementation, characteristics of patient participants, feasibility, acceptability, adoption, fidelity, and trialability will be described. Data will be collected via EMR and pharmacist and patient interviews. Median/IQR for acceptability, adoption and fidelity will be reported, and patient interviews will be analyzed using a grounded theory approach and pharmacist interviews will be analyzed using thematic analyses." @default.
• W4288753695 created "2022-07-30" @default.
• W4288753695 creator A5032953928 @default.
• W4288753695 creator A5043419293 @default.
• W4288753695 creator A5055741970 @default.
• W4288753695 creator A5059547083 @default.
• W4288753695 creator A5076440455 @default.
• W4288753695 creator A5082024441 @default.
• W4288753695 date "2022-09-01" @default.
• W4288753695 modified "2023-09-26" @default.
• W4288753695 title "Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)" @default.
• W4288753695 cites W1536602950 @default.
• W4288753695 cites W1599718530 @default.
• W4288753695 cites W1835672070 @default.
• W4288753695 cites W1848529957 @default.
• W4288753695 cites W1991073652 @default.
• W4288753695 cites W1995705474 @default.
• W4288753695 cites W2010407835 @default.
• W4288753695 cites W2011868643 @default.
• W4288753695 cites W2054763716 @default.
• W4288753695 cites W2070594825 @default.
• W4288753695 cites W2105691345 @default.
• W4288753695 cites W2132696690 @default.
• W4288753695 cites W2166270808 @default.
• W4288753695 cites W2172642397 @default.
• W4288753695 cites W2284819073 @default.
• W4288753695 cites W2563130015 @default.
• W4288753695 cites W2579374400 @default.
• W4288753695 cites W2588422719 @default.
• W4288753695 cites W2620248921 @default.
• W4288753695 cites W2622422839 @default.
• W4288753695 cites W2735666611 @default.
• W4288753695 cites W2750615195 @default.
• W4288753695 cites W2803582831 @default.
• W4288753695 cites W2807303988 @default.
• W4288753695 cites W2906994370 @default.
• W4288753695 cites W2911679306 @default.
• W4288753695 cites W2923382232 @default.
• W4288753695 cites W2976781573 @default.
• W4288753695 cites W2978535034 @default.
• W4288753695 cites W2990422537 @default.
• W4288753695 cites W3144565400 @default.
• W4288753695 cites W3159761750 @default.
• W4288753695 cites W32006757 @default.
• W4288753695 cites W3204604646 @default.
• W4288753695 cites W4241818887 @default.
• W4288753695 doi "https://doi.org/10.1016/j.rcsop.2022.100163" @default.
• W4288753695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35957656" @default.
• W4288753695 hasPublicationYear "2022" @default.
• W4288753695 type Work @default.
• W4288753695 citedByCount "1" @default.
• W4288753695 countsByYear W42887536952023 @default.
• W4288753695 crossrefType "journal-article" @default.
• W4288753695 hasAuthorship W4288753695A5032953928 @default.
• W4288753695 hasAuthorship W4288753695A5043419293 @default.
• W4288753695 hasAuthorship W4288753695A5055741970 @default.
• W4288753695 hasAuthorship W4288753695A5059547083 @default.
• W4288753695 hasAuthorship W4288753695A5076440455 @default.
• W4288753695 hasAuthorship W4288753695A5082024441 @default.
• W4288753695 hasBestOaLocation W42887536951 @default.
• W4288753695 hasConcept C10446079 @default.
• W4288753695 hasConcept C104863432 @default.
• W4288753695 hasConcept C121608353 @default.
• W4288753695 hasConcept C126322002 @default.
• W4288753695 hasConcept C143998085 @default.
• W4288753695 hasConcept C159110408 @default.
• W4288753695 hasConcept C195910791 @default.
• W4288753695 hasConcept C2426938 @default.
• W4288753695 hasConcept C2777938653 @default.
• W4288753695 hasConcept C2778461978 @default.
• W4288753695 hasConcept C2779457091 @default.
• W4288753695 hasConcept C512399662 @default.
• W4288753695 hasConcept C71924100 @default.
• W4288753695 hasConceptScore W4288753695C10446079 @default.
• W4288753695 hasConceptScore W4288753695C104863432 @default.
• W4288753695 hasConceptScore W4288753695C121608353 @default.
• W4288753695 hasConceptScore W4288753695C126322002 @default.
• W4288753695 hasConceptScore W4288753695C143998085 @default.
• W4288753695 hasConceptScore W4288753695C159110408 @default.
• W4288753695 hasConceptScore W4288753695C195910791 @default.
• W4288753695 hasConceptScore W4288753695C2426938 @default.
• W4288753695 hasConceptScore W4288753695C2777938653 @default.
• W4288753695 hasConceptScore W4288753695C2778461978 @default.
• W4288753695 hasConceptScore W4288753695C2779457091 @default.
• W4288753695 hasConceptScore W4288753695C512399662 @default.
• W4288753695 hasConceptScore W4288753695C71924100 @default.
• W4288753695 hasFunder F4320307770 @default.
• W4288753695 hasFunder F4320309151 @default.
• W4288753695 hasFunder F4320309652 @default.
• W4288753695 hasFunder F4320332511 @default.
• W4288753695 hasLocation W42887536951 @default.
• W4288753695 hasLocation W42887536952 @default.
• W4288753695 hasLocation W42887536953 @default.
• W4288753695 hasOpenAccess W4288753695 @default.
• W4288753695 hasPrimaryLocation W42887536951 @default.
• W4288753695 hasRelatedWork W2052892900 @default.
• W4288753695 hasRelatedWork W2260182467 @default.
• W4288753695 hasRelatedWork W2391422502 @default.

• next